The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients

Eur Respir J. 2014 Aug;44(2):527-9. doi: 10.1183/09031936.00011714. Epub 2014 May 2.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / administration & dosage*
  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Aminopyridines / therapeutic use*
  • Benzamides / therapeutic use*
  • Cholinergic Agents / therapeutic use*
  • Cyclopropanes / therapeutic use
  • Exercise Tolerance
  • Humans
  • Lung / drug effects
  • Lung / physiopathology
  • Phenotype
  • Phosphodiesterase 4 Inhibitors / therapeutic use
  • Plethysmography
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Spirometry
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Aminopyridines
  • Benzamides
  • Cholinergic Agents
  • Cyclopropanes
  • Phosphodiesterase 4 Inhibitors
  • Roflumilast